Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00590798 · ClinicalTrials.gov registry record · NA
Star-Close Early Ambulation Trial
A NA study of Cardiovascular Disease, sponsored by Ernest Mazzaferri.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
- 1
- Study location
NCT00590798: Completed NA study of Cardiovascular Disease, sponsored by Ernest Mazzaferri.
NCT00590798 is a NA study of Cardiovascular Disease that has completed, run by Ernest Mazzaferri. The registered enrollment target is 58 participants, below the 2,697-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00590798, a NA study of Cardiovascular Disease, has completed, sponsored by Ernest Mazzaferri.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
- 1
- Study location
Study Summary
To confirm that patients who receive the Star-Close vascular closure system (VCS) can safely ambulate within 30 minutes of catheterization.
Conditions Studied
Interventions
- BEHAVIORAL Walking
Study Locations (1)
Ohio
- The Ohio State University Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2007-04 |
| Est. Completion | 2008-12 |
| Phase | NA |
What the finished NCT00590798 record still lists
NCT00590798 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 2,697-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Cardiovascular Disease appearing as the primary indexed condition, and to 1 intervention - of which Walking is the first listed.
NCT00590798 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00590798 about?
NCT00590798 is a clinical study titled "Star-Close Early Ambulation Trial". To confirm that patients who receive the Star-Close vascular closure system (VCS) can safely ambulate within 30 minutes of catheterization.
What is the current status of trial NCT00590798?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2007-04. Estimated completion is 2008-12.
What conditions does trial NCT00590798 study?
This clinical trial studies the following conditions: Cardiovascular Disease.
What interventions are being tested in trial NCT00590798?
The interventions under investigation include: Walking (BEHAVIORAL).
Who is sponsoring clinical trial NCT00590798?
This trial is sponsored by Ernest Mazzaferri, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00590798 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00590798's enrollment target sits among peer trials
58 105th of 137 higher than 32 of 137 other Cardiovascular Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
RECRUITING · NA
-
A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
RECRUITING · NA
-
Gauging Outcomes of Total Milk Ingestion on Lipid and gControl
RECRUITING · NA
-
Determining the Benefits of Exercise on Cardiovascular Risk in PTSD
RECRUITING · NA
-
Century Trial, a Randomized Lifestyle Modification Study for Management of Stable Coronary Artery Disease
ACTIVE NOT RECRUITING · NA
-
Nitric Oxide Bioavailability and Early Life Stress (NO-Stress)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia